THE APEX TIMES
Alan Jackson discusses 15-year health battle with Charcot-Marie-Tooth as he looks toward a final concert
The country singer said he was diagnosed in 2011 with Charcot-Marie-Tooth, a neurological disease, and described the physical toll as he plans what he has called his last show.
Country singer Alan Jackson said he has been living with a long-term neurological condition as he approaches what he has described as his final concert, according to an entertainment report published June 27, 2026.
The report says Jackson was diagnosed in 2011 with Charcot-Marie-Tooth, a disease associated with nerve damage. It characterizes his experience as a “15-year health battle” and describes it as grueling, with symptoms that have compounded over time.
The account comes as Jackson made a public appearance during an event tied to the Nashville Songwriter Awards, with a photo caption indicating he spoke onstage at the 7th Annual Nashville Songwriter Awards. The report frames Jackson’s remarks as part of a broader discussion about his health and what it means for his performing schedule.
Page Six also describes the period ahead of his final concert as one in which Jackson expects continued difficulty managing the condition, with his ability to perform affected by the ongoing illness.
While Charcot-Marie-Tooth is referenced in the report in connection with nerve damage and the singer’s diagnosis timeline, the reporting does not provide specific medical treatment details, symptom progression milestones, or day-by-day limitations in the published item.
The report’s central points focus on the diagnosis date, the length of the illness, and Jackson’s own emphasis on how the condition has shaped his life and work. It presents the upcoming final concert as a key marker in the arc of his career amid that health reality.
No additional venue, date, or formal production details for the “final concert” were included in the Page Six item used for this coverage. Further information may be needed from official tour or promoter announcements to confirm logistics and any accommodations for attendees, based on whatever Jackson’s team releases publicly.
Why It Matters
- Jackson’s remarks underline how chronic neurological conditions can affect public performances and tour planning over extended periods.
- A final-concert framing increases audience attention on timing and accessibility, including how events may need to account for the performer’s health.
- Because the report does not include full logistics for the final show, official announcements will be important for ticket holders and media outlets seeking confirmed details.
- The discussion may also renew public awareness of Charcot-Marie-Tooth and the practical effects of nerve damage on daily functioning and work in live entertainment.
Key Facts
- A June 27, 2026 report says Alan Jackson is planning what he has called his final concert amid a long-running health struggle.
- The report says Jackson was diagnosed with Charcot-Marie-Tooth in 2011.
- Charcot-Marie-Tooth is described in the report as a neurological disease associated with nerve damage.
- The report characterizes the illness as a grueling 15-year battle.
- A photo caption tied to the reporting indicates Jackson spoke onstage at the 7th Annual Nashville Songwriter Awards.